Compounds > moxifloxacin
Page last updated: 2024-09-04

moxifloxacin and Flavobacteriaceae Infections

moxifloxacin has been researched along with Flavobacteriaceae Infections in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Ahmed, MA; Al Aidaroos, AY; Al Doghaim, FS; Al Odayani, A; Albehlal, LB; AlQasim, MA; Alyami, AM; Kaabia, NM1
Boucher, BA; Croce, MA; Fabian, TC; Monteen, MR; Ponnapula, S; Swanson, JM; Wood, GC1

Other Studies

2 other study(ies) available for moxifloxacin and Flavobacteriaceae Infections

ArticleYear
Chryseobacterium/Elizabethkingia species infections in Saudi Arabia.
    Saudi medical journal, 2020, Volume: 41, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; Chryseobacterium; Drug Resistance, Bacterial; Female; Flavobacteriaceae Infections; Humans; Infant; Infant, Newborn; Male; Middle Aged; Moxifloxacin; Retrospective Studies; Saudi Arabia; Trimethoprim, Sulfamethoxazole Drug Combination; Young Adult

2020
Treatment of Chryseobacterium indologenes ventilator-associated pneumonia in a critically ill trauma patient.
    The Annals of pharmacotherapy, 2013, Volume: 47, Issue:12

    Topics: Aged; Anti-Bacterial Agents; Aza Compounds; Cefepime; Cephalosporins; Chryseobacterium; Critical Illness; Flavobacteriaceae Infections; Fluoroquinolones; Humans; Intensive Care Units; Male; Moxifloxacin; Pneumonia, Ventilator-Associated; Quinolines; Radiography; Wounds and Injuries

2013